Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Basurto

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical ResearchF Roila, M Tonato, C Basurto, et al.
Breast Cancer Research and Treatment|January 1, 1996
Salvage chemotherapy in metastatic breast cancer: an experience with the combination of mitoxantrone, 5-fluorouracil, and L-leucovorinM Colozza, S Gori, A M Mosconi, et al.
Cancer Treatment Reports|December 1, 1985
Antiemetic activity of two different high doses of metoclopramide in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical ResearchF Roila, M Tonato, C Basurto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1991
Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scalesF Roila, M Lupattelli, M Sassi, et al.
American Journal of Clinical Oncology|June 1, 1991
Predictive factors of delayed emesis in cisplatin-treated patients and antiemetic activity and tolerability of metoclopramide or dexamethasone. A randomized single-blind studyF Roila, E Boschetti, M Tonato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical ResearchF Roila, M Tonato, C Basurto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Reliability and validity of a quality of life questionnaire in cancer patientsE Ballatori, F Roila, C Basurto, et al.
American Journal of Clinical Oncology|April 1, 1989
Chemotherapy with cis-platin, doxorubicin, and cyclophosphamide (CAP) in patients with metastatic breast cancerM Colozza, S Gori, A M Mosconi, et al.
Tumori|August 16, 2001
Results of a prospective study with high-dose etoposide, thiotepa and carboplatin and peripheral blood stem cell rescue for high-risk stage II-IIIA and selected stage IV breast cancer patientsS Gori, A M Mosconi, A Tabilio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2008
Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survivalV Ludovini, S Gori, M Colozza, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical ResearchF Roila, M Tonato, C Basurto, et al.
Breast Cancer Research and Treatment|January 1, 1996
Salvage chemotherapy in metastatic breast cancer: an experience with the combination of mitoxantrone, 5-fluorouracil, and L-leucovorinM Colozza, S Gori, A M Mosconi, et al.
Cancer Treatment Reports|December 1, 1985
Antiemetic activity of two different high doses of metoclopramide in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical ResearchF Roila, M Tonato, C Basurto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1991
Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scalesF Roila, M Lupattelli, M Sassi, et al.
American Journal of Clinical Oncology|June 1, 1991
Predictive factors of delayed emesis in cisplatin-treated patients and antiemetic activity and tolerability of metoclopramide or dexamethasone. A randomized single-blind studyF Roila, E Boschetti, M Tonato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical ResearchF Roila, M Tonato, C Basurto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Reliability and validity of a quality of life questionnaire in cancer patientsE Ballatori, F Roila, C Basurto, et al.
American Journal of Clinical Oncology|April 1, 1989
Chemotherapy with cis-platin, doxorubicin, and cyclophosphamide (CAP) in patients with metastatic breast cancerM Colozza, S Gori, A M Mosconi, et al.
Tumori|August 16, 2001
Results of a prospective study with high-dose etoposide, thiotepa and carboplatin and peripheral blood stem cell rescue for high-risk stage II-IIIA and selected stage IV breast cancer patientsS Gori, A M Mosconi, A Tabilio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2008
Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survivalV Ludovini, S Gori, M Colozza, et al.
Pageof 4